Risk factors in thyroid cancer: is the obesity pandemic an important factor?

References

• Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer – viewpoint of the IARC working group. N Engl J Med. 2016 Aug 25;375(8):794–798.
   PubMed Web of Science ®Google Scholar
• Davies L, Morris L, Hankey B. Increases in thyroid cancer incidence and mortality. Jama. 2017 Jul 25;318(4):389–390.
   PubMed Web of Science ®Google Scholar
• Ito Y, Nikiforov YE, Schlumberger M, et al. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013 Mar;9(3):178–184.
   PubMed Web of Science ®Google Scholar
• Pereira M, Williams VL, Hallanger Johnson J, et al. Thyroid cancer incidence trends in the United States: association with changes in professional guideline recommendations. Thyroid. 2020 Apr 3;30(8):1132–1140.
   PubMed Web of Science ®Google Scholar
• Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic” – screening and overdiagnosis. N Engl J Med. 2014 Nov 6;371(19):1765–1767.
   PubMed Web of Science ®Google Scholar
• Kb S, MS S. Obesity statistics. ix. Prim Care. 2016 Mar;43(1):121–135.
   PubMed Web of Science ®Google Scholar
• Whiteman DC, Wilson LF. The fractions of cancer attributable to modifiable factors: a global review. Cancer Epidemiol. 2016 Oct;44:203–221.
   PubMed Web of Science ®Google Scholar
• Soerjomataram I, Shield K, Marant-Micallef C, et al. Cancers related to lifestyle and environmental factors in France in 2015. Eur J Cancer. 2018 Dec;105:103–113.
   PubMed Web of Science ®Google Scholar
• Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019 Mar;15(3):139–154.
   PubMed Web of Science ®Google Scholar
• Marcello MA, Cunha LL, Batista FA, et al. Obesity and thyroid cancer. Endocr Relat Cancer. 2014 Oct;21(5):T255–71.
   PubMed Web of Science ®Google Scholar
• Dumas JF, Brisson L. Interaction between adipose tissue and cancer cells: role for cancer progression. Cancer Metastasis Rev. 2021 Mar;40(1):31–46.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, McCullough ML, Franceschi S, et al. Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid. 2016 Feb;26(2):306–318.
   PubMed Web of Science ®Google Scholar
• Son H, Lee H, Kang K, et al. The risk of thyroid cancer and obesity: a nationwide population-based study using the Korea National Health Insurance Corporation cohort database. Surg Oncol. 2018 Jun;27(2):166–171.
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Lise M, Clavel-Chapelon F, et al. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer J Inter du Cancer. 2012 Sep 15;131(6):E1004–14.
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Pfeiffer RM, Sosa JA, et al. Impact of overweight and obesity on U.S. papillary thyroid cancer incidence trends (1995-2015). J Natl Cancer Inst. 2020 Oct;112(8):810–817.
   Google Scholar
• Negri E, Ron E, Franceschi S, et al. Risk factors for medullary thyroid carcinoma: a pooled analysis. Cancer Causes Control. 2002 May;13(4):365–372.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Casanueva F, Haluzik M, et al. European Society of Endocrinology Clinical practice guideline: endocrine work-up in obesity. Eur J Endocrinol/Eur Fed Endocr Soc. 2020 Jan;182(1):G1–g32.
   PubMed Web of Science ®Google Scholar
• Zagzag J, Malone MK, Lopresti MA, et al. Method of detection of well-differentiated thyroid cancers in obese and non-obese patients. PloS one. 2016;11(4):e0152768.
   PubMed Web of Science ®Google Scholar
• Uppot RN, Sahani DV, Hahn PF, et al. Impact of obesity on medical imaging and image-guided intervention. AJR. 2007 Feb;188(2):433–440.
   PubMed Web of Science ®Google Scholar
• Cham S, Zanocco K, Sturgeon C, et al. Risk-based ultrasound screening for thyroid cancer in obese patients is cost-effective. Thyroid. 2014 Jun;24(6):975–986.
   PubMed Web of Science ®Google Scholar
• Matrone A, Ferrari F, Santini F, et al. Obesity as a risk factor for thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):358–363.
   PubMedGoogle Scholar
• Economides A, Giannakou K, Mamais I, et al. Association between aggressive clinicopathologic features of papillary thyroid carcinoma and body mass index: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021;12:692879.
   PubMed Web of Science ®Google Scholar
• O’Neill RJ, Abd Elwahab S, Kerin MJ, et al. Association of BMI with clinicopathological features of papillary thyroid cancer: a systematic review and meta-analysis. World J Surg. 2021 Sep;45(9):2805–2815.
   PubMed Web of Science ®Google Scholar
• Matrone A, Ceccarini G, Beghini M, et al. Potential impact of BMI on the aggressiveness of presentation and clinical outcome of differentiated thyroid cancer. J Clin Endocrinol Metab. 2020 1; 105(4): Apr.
   Web of Science ®Google Scholar
• Gasior-Perczak D, Palyga I, Szymonek M, et al. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer. PloS one. 2018;13(10):e0204668.
   PubMed Web of Science ®Google Scholar
• Grani G, Lamartina L, Montesano T, et al. Lack of association between obesity and aggressiveness of differentiated thyroid cancer. J Endocrinol Invest. 2019 Jan;42(1):85–90.
   PubMed Web of Science ®Google Scholar
• Kim JM. The clinical importance of overweight or obesity on tumor recurrence in papillary thyroid carcinoma. Gland Surg. 2022 Jan;11(1):35–41.
   PubMed Web of Science ®Google Scholar
• Cui N, Sun Q, Chen L. A meta-analysis of the influence of body mass index on the clinicopathologic progression of papillary thyroid carcinoma. Medicine (Baltimore). 2021 Aug 13;100(32):e26882.
   PubMed Web of Science ®Google Scholar
• Elisei R, Ugolini C, Viola D, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study [research support, Non-U.S. Gov’t]. J Clin Endocrinol Metab. 2008 Oct;93(10):3943–3949.
   PubMed Web of Science ®Google Scholar
• Rahman ST, Pandeya N, Neale RE, et al. Obesity is associated with BRAF(V600E)-mutated thyroid cancer. Thyroid. 2020 Oct;30(10):1518–1527.
   PubMed Web of Science ®Google Scholar
• Stommel M, Schoenborn CA. Accuracy and usefulness of BMI measures based on self-reported weight and height: findings from the NHANES & NHIS 2001-2006. BMC Public Health. 2009 Nov 19;9:421.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer [research support, Non-U.S. Gov’t]. Thyroid. 2015 [2016 Jan];26(1):1–133.
   Web of Science ®Google Scholar
• Pacini F, Basolo F, Bellantone R, et al. Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest. 2018 Jul;41(7):849–876.
   PubMed Web of Science ®Google Scholar